V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20174214 | 20088078 | 1.78 | 77.5 | Palliative (P) | 2017-02-08 | 2017-02-09 | TRASTUZUMAB EMTANSINE | 02 | N | NEO-AEGIS TRIAL | 101334088 |
| 20174446 | 20088079 | 1.66 | 0 | Palliative (P) | 2015-08-11 | 2015-08-27 | Panitumumab | 02 | N | FEC + DOCETAXEL | 100430350 |
| 20174684 | 20088080 | 1.71 | 80 | null | 2018-12-13 | 2018-12-22 | ARISTOTLE TRIAL | null | Y | ACELARATE TRIAL | 101376674 |
| 20174697 | 20088081 | 1.76 | 57.2 | 03 | null | 2018-05-21 | NEO-AEGIS TRIAL | 02 | N | SCOPE2 TRIAL | 100223561 |
| 20174777 | 20088082 | 1.63 | 70.3 | 03 | 2018-05-05 | 2018-05-09 | CHOP R - 21 days | 01 | N | BENDAMUSTINE + RITUXIMAB | 101564279 |
| 20174811 | 20088083 | 1.65 | 62.2 | Palliative (P) | 2017-02-27 | 2017-03-05 | Cladribine (subcut) 5 days | 01 | null | CARBOPLATIN + RT | 100027629 |
| 20175160 | 20088084 | 1.77 | 72.8 | Palliative (P) | 2016-06-03 | 2016-06-06 | Docetaxel | null | N | SCOPE2 TRIAL | 100150590 |
| 20175176 | 20088085 | 0 | 0 | Palliative (P) | 2017-02-22 | 2017-02-24 | LENALIDOMIDE | Y | N | CAPECITABINE + CETUXIMAB + IRINOTECAN | 101667944 |
| 20175225 | 20088086 | 1.67 | 115 | null | 2018-11-18 | 2018-12-02 | Carboplatin + Pemetrexed | 02 | N | CISPLATIN + FLUOROURACIL + RT | 101497599 |
| 20175253 | 20088087 | 1.68 | 81 | 03 | 2017-03-01 | 2017-03-12 | Panitumumab | 02 | N | DOCETAXEL | 100827231 |
| 20175290 | 20088088 | 1.58 | 89 | Palliative (P) | 2018-02-25 | 2018-02-28 | Docetaxel 75mg/m2 (21 day) | N | null | ESPAC TRIAL | 101297314 |
| 20175362 | 20088089 | 1.79 | 78.4 | 03 | 2019-02-02 | 2019-02-02 | Rituximab | Y | Y | RALTITREXED | 100774862 |
| 20175646 | 20088090 | 1.8 | 110 | Curative (C) | 2018-01-25 | 2018-02-05 | Docetaxel 75mg/m2 (21 day) | 02 | N | HYDROXYCARBAMIDE | 100966988 |
| 20175696 | 20088091 | 1.69 | 55.3 | Palliative (P) | null | 2018-02-09 | Cytarabine Low Dose | N | N | BEVACIZUMAB + CAPECITABINE + OXALIPLATIN | 100154282 |
| 20175860 | 20088093 | 1.53 | 61.8 | null | 2018-08-07 | 2018-08-14 | MITOMYCIN | 01 | N | EOF | 101851228 |
| 20176343 | 20088094 | 1.74 | 88.6 | Adjuvant (A) | 2022-03-10 | 2022-03-10 | Bendamustine+Rituximab (1st Course) | 02 | N | BALLAD TRIAL | 100305895 |
| 20176423 | 20088095 | 0.6 | 78.65 | Palliative (P) | 2015-11-15 | 2015-11-28 | CARBOPLATIN + FLUOROURACIL | 02 | N | CAPITAL TRIAL | 101225019 |
| 20176594 | 20088096 | 1.49 | 63.6 | Palliative (P) | 2019-10-31 | 2019-11-19 | Gemcitabine + Paclitaxel | 02 | N | RALTITREXED | 101047090 |
| 20176608 | 20088097 | 1.63 | 60 | Curative (C) | 2019-04-20 | 2019-04-27 | GEMCARBO | null | Y | NOT MATCHED | 101408911 |
| 20176672 | 20088098 | 1.85 | 58.2 | 03 | 2018-03-03 | 2018-03-09 | Carboplatin+Fluorouracil 4 or 5 day | N | N | OXALIPLATIN + MDG + PANITUMUMAB | 100764749 |
| 20176772 | 20088100 | 1.66 | 86.8 | null | 2017-07-02 | 2017-07-03 | Cisplatin + Fluorouracil + Streptozocin | N | Y | TRABECTEDIN | 101801059 |
| 20176782 | 20088101 | 1.85 | 73.45 | Adjuvant (A) | 2019-10-23 | 2019-11-02 | PLATO Trials | 02 | N | PLATO TRIAL | 100758984 |
| 20177135 | 20088102 | 1.78 | 83.6 | Neo-adjuvant (N) | 2018-07-13 | 2018-07-26 | Capital Trial | 02 | N | FOXTROT TRIAL | 100067209 |
| 20177203 | 20088103 | 1.61 | 59.85 | 03 | 2017-06-11 | 2017-06-22 | ACTICCA-1 Trial | 02 | N | REGORAFENIB | 100570393 |
| 20177276 | 20088104 | 1.78 | 66.2 | Palliative (P) | 2022-04-10 | 2022-04-15 | EEF or EOF | 02 | N | SUNITINIB | 101803483 |
| 20177353 | 20088105 | 1.6 | 62 | Palliative (P) | 2021-06-28 | 2021-07-12 | FCiSt | N | N | CARBOPLATIN + VINORELBINE | 100997655 |
| 20177553 | 20088107 | 0 | 0 | Palliative (P) | null | 2019-11-09 | MITOMYCIN | N | Y | DOCETAXEL | 100565509 |
| 20177749 | 20088108 | null | 81.9 | 03 | 2017-09-01 | 2017-09-08 | Cladribine (subcut) 5 days | 02 | N | PLATO TRIAL | 100823814 |
| 20177853 | 20088109 | 1.67 | 67 | 03 | 2019-09-11 | 2019-09-25 | CARBOPLATIN + FLUOROURACIL | 02 | N | ACTICCA-1 TRIAL | 100665899 |
| 20178167 | 20088110 | 1.7 | 80.8 | 03 | 2019-12-27 | 2020-01-10 | AML18 PILOT TRIAL | N | N | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE | 101648534 |
| 20178247 | 20088111 | 1.78 | 76 | Adjuvant (A) | 2017-07-17 | 2017-07-18 | Ixazomib + Lenalidomide | N | N | CARBOPLATIN + FLUOROURACIL | 100397553 |
| 20178495 | 20088113 | 1.69 | 64 | Adjuvant (A) | 2017-10-04 | 2017-10-11 | POMALIDOMIDE | 02 | N | CAPECITABINE + IRINOTECAN + PANITUMUMAB | 100650283 |
| 20178586 | 20088114 | 1.77 | 68.4 | Palliative (P) | 2022-03-07 | 2022-03-07 | null | 02 | N | ANAGRELIDE | 101870276 |
| 20178692 | 20088115 | 1.76 | 78.4 | null | 2019-07-02 | 2019-08-02 | CYCLO + DOXORUBICIN + VINCRISTINE | 02 | N | OXALIPLATIN | 101741981 |
| 20178873 | 20088116 | 1.88 | 58.8 | Palliative (P) | 2016-09-09 | 2016-10-06 | Acalabrutinib | N | null | CISPLATIN + RT | 100843706 |
| 20178883 | 20088117 | 1.69 | 93 | 03 | 2020-01-28 | 2020-02-05 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | STS NON-RHABDO EPSSG 2005 VDCY | 100092453 |
| 20179768 | 20088119 | 1.8 | 87.7 | Palliative (P) | 2019-10-23 | 2019-10-26 | MITOMYCIN | 02 | N | EVEROLIMUS | 101626292 |
| 20180081 | 20088120 | 1.75 | 84.9 | 03 | 2018-02-06 | 2018-03-07 | AZACITIDINE + VENETOCLAX | 02 | N | RUXOLITINIB | 100358723 |
| 20180220 | 20088121 | 1.57 | 119 | 03 | 2019-11-22 | 2019-11-22 | Docetaxel 75mg/m2 (21 day) | 02 | Y | SCOPE2 TRIAL | 100550424 |
| 20180262 | 20088122 | 1.89 | 75 | Palliative (P) | 2018-12-15 | 2018-12-17 | CAP + RT | 02 | N | EPIRUBICIN + ETOPOSIDE + IFOSFAMIDE | 101469714 |
| 20180316 | 20088123 | 1.62 | 91 | 03 | 2018-11-09 | 2018-11-23 | IPILIMUMAB + NIVOLUMAB | 02 | N | ESPAC TRIAL | 100049470 |
| 20180332 | 20088124 | 1.77 | 53 | 03 | 2015-05-11 | 2015-05-18 | CHOEP | 02 | Y | CHOP R | 101711506 |
| 20180381 | 20088125 | 1.66 | 81.1 | 03 | 2018-10-28 | 2018-11-07 | null | N | N | CAPECITABINE + IRINOTECAN + RT | 100722021 |
| 20180599 | 20088126 | 1.89 | 14.8 | null | 2017-10-02 | 2017-10-20 | OXALIPLATIN + MDG + PANITUMUMAB | N | N | CAPECITABINE + CETUXIMAB + OXALIPLATIN | 100287199 |
| 20180904 | 20088127 | 1.6 | 82.9 | null | 2017-02-06 | 2017-02-07 | null | 01 | N | RADIUM 223 | 100544999 |
| 20180926 | 20088128 | 1.5 | 82 | null | 2019-08-13 | 2019-08-24 | CISPLATIN + RT | 02 | N | MELPHALAN | 100350853 |
| 20181988 | 20088130 | null | null | 03 | null | 2021-08-23 | CARBOPLATIN + VINORELBINE | Y | N | SUNITINIB | 101798798 |
| 20182147 | 20088132 | 1.71 | 78.9 | 03 | 2016-06-09 | 2016-06-09 | LENALIDOMIDE | 02 | N | NEO-AEGIS TRIAL | 101510421 |
| 20182155 | 20088133 | 1.78 | 89 | Palliative (P) | 2019-03-27 | 2019-03-27 | CHOP R - 21 days | 01 | N | AZACITIDINE | 101007419 |
| 20182177 | 20088134 | 1.69 | 67.5 | Palliative (P) | null | 2018-12-04 | Pazopanib | null | N | NOT MATCHED | 100068210 |